Menu
NASP

All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and latest CE information More Information

Featured Activity

This activity will cover key topics of interest to stakeholders who set practice policy and will be called upon to evaluate and make decisions on issues pertaining to biosimilars.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

SHOW SEARCH

Managed Care Payers and Understanding Specialty Pharmacy Expectations

To Participate

To participate in this continuing education activity:

  1. Review the activity description and objectives.
  2. View the activity.
  3. Complete the online post-test and activity evaluation.
A product of the National Association of Specialty Pharmacy's (NASP) Center for Specialty Pharmacy Education (CSPE) 

 
 View more NASP/CSPE Activities
 

NOTE: If you attended the live CE activity titled "Managed Care Payers and Understanding Specialty Pharmacy Expectations" that was held on September 28, 2016 during the NASP Annual Meeting & Expo in Washington, DC AND received CE credit (i.e. a pharmacist CE statement with ACPE Universal Activity Number 0221-9999-16-196-L04-P), you are ineligible to also receive CE credit for this home-study activity.

Activity Description

This is a featured CE activity on the Center for Specialty Pharmacy Education (CSPE) website. CSPE is the educational hub of the National Association of Specialty Pharmacy (NASP). This activity was originally presented during the National Association of Specialty Pharmacy Fourth Annual Meeting & Expo held in Washington, DC. During this session, the participant will hear from experienced Payer executives with decades of experience as they review and discuss the importance and evolution of the Payer- Specialty Pharmacy Relationship. Learn about current and future innovative service collaborations that can differentiate specialty pharmacies and further add to their value proposition in clinical and benefits management.

Learning Objectives

The target audience for this activity is pharmacists. Upon completion of this activity, participants will be able to:

  • List 5 minimum standards important to Payers that Specialty Pharmacy need to provide to be even considered for some Payer RFPs.
  • Describe at least 3 different innovative services that Specialty Pharmacy has developed and provided to Payers that have demonstrated improved care and lower costs.
  • Outline variables to consider for constructing a new program or intervention that will help address and mitigate an important issue being faced now or in the future by health care providers, members or Plans regarding specialty medication.
  • Identify the key issues that Payers will need addressed and the value added by specialty pharmacy relative to a new specialty drug being available on the market.

Faculty

Moderator: Joel Owerbach, PharmD
Consultant
Pharmaceuticals Strategy Solutions

James R. Lang, PharmD, MBA
VP, Pharmacy Services
Blue Cross Blue Shield of Michigan

Neil B. Minkoff, MD
Chief Medical Officer
EmpiraMed, Inc.

Michael White, PharmD
Director, Clinical Pharmacy
BlueCross BlueShield of Tennessee

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Joel Owerbach has served as a Consultant and/or Speaker for Daiichi-Sankyo, Forum Pharmaceuticals, Genentech, and Novo Nordisk. James Lang, Neil Minkoff, and Michael White do not have any relevant commercial or financial relationships to disclose.

The opinions expressed in this activity should not be construed as those of the CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs for unlabeled indications. Use of drugs outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.

CE Accreditation

Release Date: 12-01-2016
Expiration Date: 12-01-2017

Pharmacists

This CE activity is jointly provided by ProCE, Inc. and NASP. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-16-348-H04-P has been assigned to this knowledge-based home-study CE activity (initial release date 12-01-16). This activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. Completion of the evaluation and the post-test with a score of 70% or higher are required to receive CE credit. No partial credit will be given.

Funding

No external support has been received for this activity.

 

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.